Search
Ketotifen H1-Antihistamine Action
smpdb.ca/view/SMP0059868Drug actionReducing the activity of the NF-κB immune response transcription factor through the phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the expression
Enzymes: Protein kinase C beta type, Guanine nucleotide-binding protein G(q) subunit alphaOlopatadine H1-Antihistamine Action
smpdb.ca/view/SMP0060740Drug actionReducing the activity of the NF-κB immune response transcription factor through the phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the expression
Enzymes: Protein kinase C beta type, Guanine nucleotide-binding protein G(q) subunit alphaMethapyrilene H1-Antihistamine Action
smpdb.ca/view/SMP0058741Drug actionReducing the activity of the NF-κB immune response transcription factor through the phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the expression
Enzymes: Protein kinase C beta type, Guanine nucleotide-binding protein G(q) subunit alphaBezafibrate Action Pathway (New)
smpdb.ca/view/SMP0125291Drug actionOther proteins that affect LPL are also altered. For instance, APOA5 activates LPL and it’s expression is increased with bezafibrate. … This PPARα-RXRα complex regulate gene transcription/translation of proteins and enzymes involved lipolysis, fatty acid transport and biosynthesis, vLDL and HDL synthesis.
Enzymes: Long-chain fatty acid transport protein 1, Apolipoprotein C-IIIGemfibrozil Action Pathway
smpdb.ca/view/SMP0125290Drug actionOther proteins that affect LPL are also altered. For instance, APOA5 activates LPL and it’s expression is increased with gemfibrozil. … This PPARα-RXRα complex regulate gene transcription/translation of proteins and enzymes involved lipolysis, fatty acid transport and biosynthesis, vLDL and HDL synthesis.
Enzymes: Long-chain fatty acid transport protein 1, Apolipoprotein C-IIIBetahistine H1-Antihistamine Action
smpdb.ca/view/SMP0060744Drug actionReducing the activity of the NF-κB immune response transcription factor through the phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the expression
Enzymes: Protein kinase C beta type, Guanine nucleotide-binding protein G(q) subunit alphaOlanzapine H1-Antihistamine Immune Response Action Pathway
smpdb.ca/view/SMP0175108Drug actionReducing the activity of the NF-κB immune response transcription factor through the phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the expression
Enzymes: Protein kinase C beta type, Protein kinase C alpha typeDiphenhydramine H1-Antihistamine Immune Response Action Pathway
smpdb.ca/view/SMP0175086Drug actionReducing the activity of the NF-κB immune response transcription factor through the phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the expression
Enzymes: Protein kinase C beta type, Protein kinase C alpha typeAntazoline H1-Antihistamine Action
smpdb.ca/view/SMP0057584Drug actionReducing the activity of the NF-κB immune response transcription factor through the phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the expression
Enzymes: Protein kinase C beta type, Guanine nucleotide-binding protein G(q) subunit alphaTalastine H1-Antihistamine Action
smpdb.ca/view/SMP0057586Drug actionReducing the activity of the NF-κB immune response transcription factor through the phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the expression
Enzymes: Protein kinase C beta type, Guanine nucleotide-binding protein G(q) subunit alpha